These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19470869)

  • 21. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of pulse pressure, systolic blood pressure, and diastolic blood pressure in the prediction of cardiovascular risk. Cohort study].
    Baena-Díez JM; Bermúdez-Chillida N; García-Lareo M; Olivia Byram A; Vidal-Solsona M; Vilató-García M; Gómez-Fernández C; Vásquez-Lazo JE
    Med Clin (Barc); 2008 Mar; 130(10):361-5. PubMed ID: 18381026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
    Greenberg J
    Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
    Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
    J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.
    Mucalo I; Jovanovski E; Rahelić D; Božikov V; Romić Z; Vuksan V
    J Ethnopharmacol; 2013 Oct; 150(1):148-53. PubMed ID: 23973636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure as a predictor of cardiovascular events in the elderly: the William Hale Research Program.
    Masley SC; Phillips SE; Schocken DD
    J Hum Hypertens; 2006 Jun; 20(6):392-7. PubMed ID: 16543911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
    Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
    BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes.
    Noguchi Y; Asayama K; Staessen JA; Inaba M; Ohkubo T; Hosaka M; Satoh M; Kamide K; Awata T; Katayama S; Imai Y;
    J Hypertens; 2013 Aug; 31(8):1593-602. PubMed ID: 23673350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood pressure control by antihypertensive agents in people older than 60].
    Perret-Guillaume C; Miget P; Aubry C; Gueguen R; Steyer E; Bénétos A
    Rev Med Interne; 2006 Apr; 27(4):285-90. PubMed ID: 16517028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender differences in the accuracy of time-dependent blood pressure indices for predicting coronary heart disease: A random-effects modeling approach.
    Brant LJ; Ferrucci L; Sheng SL; Concin H; Zonderman AB; Kelleher CC; Longo DL; Ulmer H; Strasak AM
    Gend Med; 2010 Dec; 7(6):616-27. PubMed ID: 21195361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
    Navar AM; Gallup DS; Lokhnygina Y; Green JB; McGuire DK; Armstrong PW; Buse JB; Engel SS; Lachin JM; Standl E; Van de Werf F; Holman RR; Peterson ED;
    Hypertension; 2017 Nov; 70(5):907-914. PubMed ID: 28847886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family history of diabetes modifies the effect of blood pressure for incident diabetes in Middle Eastern women: Tehran Lipid and Glucose Study.
    Hatami M; Hadaegh F; Khalili D; Sheikholeslami F; Azizi F
    J Hum Hypertens; 2012 Feb; 26(2):84-90. PubMed ID: 21289645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.